- Home
- PXLW vs ANTX Comparison
PXLW vs ANTX Comparison
Compare PXLW & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXLW
- ANTX
- Stock Information
- Founded
- PXLW 1997
- ANTX 2017
- Country
- PXLW United States
- ANTX United States
- Employees
- PXLW N/A
- ANTX N/A
- Industry
- PXLW Semiconductors
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- PXLW Technology
- ANTX Health Care
- Exchange
- PXLW Nasdaq
- ANTX Nasdaq
- Market Cap
- PXLW 49.1M
- ANTX 41.8M
- IPO Year
- PXLW 2000
- ANTX 2022
- Fundamental
- Price
- PXLW $0.63
- ANTX $1.40
- Analyst Decision
- PXLW Strong Buy
- ANTX Hold
- Analyst Count
- PXLW 3
- ANTX 5
- Target Price
- PXLW $2.17
- ANTX $3.50
- AVG Volume (30 Days)
- PXLW 244.3K
- ANTX 96.0K
- Earning Date
- PXLW 05-13-2025
- ANTX 03-25-2025
- Dividend Yield
- PXLW N/A
- ANTX N/A
- EPS Growth
- PXLW N/A
- ANTX N/A
- EPS
- PXLW N/A
- ANTX N/A
- Revenue
- PXLW $43,206,000.00
- ANTX N/A
- Revenue This Year
- PXLW $10.25
- ANTX N/A
- Revenue Next Year
- PXLW $39.19
- ANTX N/A
- P/E Ratio
- PXLW N/A
- ANTX N/A
- Revenue Growth
- PXLW N/A
- ANTX N/A
- 52 Week Low
- PXLW $0.60
- ANTX $0.87
- 52 Week High
- PXLW $2.63
- ANTX $3.88
- Technical
- Relative Strength Index (RSI)
- PXLW 37.21
- ANTX 54.19
- Support Level
- PXLW $0.70
- ANTX $1.28
- Resistance Level
- PXLW $0.77
- ANTX $1.55
- Average True Range (ATR)
- PXLW 0.05
- ANTX 0.07
- MACD
- PXLW -0.00
- ANTX -0.01
- Stochastic Oscillator
- PXLW 11.33
- ANTX 40.74
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in China.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.